A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- NauseaVomiting
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 32
- Registration Number
- NCT00618111
- Locations
- ๐บ๐ธ
MDS Pharma Services, Lincoln, Nebraska, United States
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- SeizuresEpilepsy
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00616863
- Locations
- ๐จ๐ฆ
MDS Pharma Services, Montreal, Quebec, Canada
Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- SeizuresEpilepsy
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00616681
- Locations
- ๐จ๐ฆ
MDS Pharma Services, Montreal, Quebec, Canada
Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions
Not Applicable
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00601575
- Locations
- ๐บ๐ธ
Arkansas Research, Little Rock, Arkansas, United States
Bioequivalency Study of Zolpidem Tartrate Under Fed Conditions
Not Applicable
Completed
- Conditions
- Insomnia
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00602719
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Torsemide Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Edema
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00602615
- Locations
- ๐บ๐ธ
Bio-Kinetic Clinical Applications, Inc., Springfield, Missouri, United States
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- HypertensionChronic Stable AnginaVasospastic Angina
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 40
- Registration Number
- NCT00602017
- Locations
- ๐บ๐ธ
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Bioequivalency Study of Sertraline Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Depression
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 38
- Registration Number
- NCT00602849
- Locations
- ๐จ๐ฆ
Anapharm Inc., Sainte-Fly, Quebec, Canada
Bioequivalency Study of Zidovudine Under Fasting Conditions
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 52
- Registration Number
- NCT00602550
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, Austin, Texas, United States
Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Infection
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 40
- Registration Number
- NCT00601315
- Locations
- ๐บ๐ธ
MDS Pharma Services, Phoenix, Arizona, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath